ISTA Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. ISTA Pharmaceuticals, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
ISTA Pharmaceuticals (ISTA) is an ophthalmic pharmaceutical company engaged in the development and commercialization of products for the treatment of inflammation, ocular pain, glaucoma, allergy and dry eye. The company primarily operates in the US. It is headquartered in Irvine, California and employed 326 people as of January 31, 2011. The company recorded revenues of $156.5 million during the financial year (FY) ended December 2010, an increase of 41.5% over FY2009. The operating profit of the company was $10.4 million during FY2010, as compared to an operating profit of $2.1 million in FY2009. The net loss was $5.3 million in FY2010, as compared to a net loss of $57.8 million in FY2009.
Scope of the Report
Provides all the crucial information on ISTA Pharmaceuticals, Inc. required for business and competitor intelligence needs
Contains a study of the major internal and external factors affecting ISTA Pharmaceuticals, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of ISTA Pharmaceuticals, Inc.
Data is supplemented with details on ISTA Pharmaceuticals, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from ISTA Pharmaceuticals, Inc.
Reasons to Purchase
Support sales activities by understanding your customers’ businesses better
Understand prospective partners and suppliers
Keep fully up to date on your competitors’ business structure, strategy and prospects
Obtain the most up to date company information available